This trial is unknown!
Search for a recruiting clinical trial for your condition
Your journey
1What's a trial
2Find
3Review
4Get in touch
More info
You can access this
clinical trial
if you have
Gastric Adenocarcinoma
and you are
between 20 and 75
years old
3
This is a trial in the final phase before the treatment is released on the market.
Show me locations

The purpose

This is a randomized, multicenter, controlled trial to prove efficacy of S‐1 and Oxaliplatin as Neoadjuvant Chemotherapy for Advanced Gastric Cancer Patients who undergo D2 gastrectomy. The primary endpoint is three-year free disease and the second primary includes five-year overall survival, safety and R0 resection rate.

Provided treatments

  • Drug: Oxaliplatin+S-1
  • Drug: Adjuvant Oxaliplatin/S-1(SOX)

Locations near you

Unfortunately, there are no recruiting locations near you. Please check the list with all locations below.
Tris trial is registered with FDA with number: NCT01583361. The sponsor of the trial is Lin Chen and it is looking for 772 volunteers for the current phase.
Official trial title:
Phase III, Randomized, Multicenter, Controlled Evaluation of S‐1 and Oxaliplatin as Neoadjuvant Chemotherapy for Advanced Gastric Cancer Patients